Mike Holfinger

No más puestos en curso

Health Technology

Consumer Services

Perfil

Mike Holfinger worked as Vice President of Manufacturing at Alexza Pharmaceuticals, Inc. from 2013 to 2015.
Prior to that, he held the same position at Affymax, Inc. from 2006 to 2013.
He also worked as Vice President of Manufacturing and Supply Chain at Aimmune Therapeutics, Inc. Dr. Holfinger received an undergraduate degree from Miami University and a doctorate degree from the University of Wisconsin.

Antiguos cargos conocidos de Mike Holfinger.

Empresas	Cargo	Fin
ALEXZA PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/06/2013
AFFYMAX, INC.	Corporate Officer/Principal	01/06/2013
AIMMUNE THERAPEUTICS, INC.	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Mike Holfinger.

Formación de Mike Holfinger.

Miami University	Undergraduate Degree
University of Wisconsin	Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Mike Holfinger.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
AFFYMAX, INC.	Health Technology

Empresas privadas	2
Alexza Pharmaceuticals, Inc. Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA.	Health Technology
Aimmune Therapeutics, Inc. Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA.	Health Technology